Your browser doesn't support javascript.
loading
Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data.
Zhang, Xiaowei; Jin, Feng; Jiang, Shiyu; Cao, Jun; Meng, Yanchun; Xu, Yu; Chen, Yong; Yang, Huijuan; Kong, Yunyi; Liu, Xin; Luo, Zhiguo.
Afiliação
  • Zhang X; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Jin F; Department of Digestive Disease, 900Th Hospital of Joint Logistics Support Force, Fuzhou, 350002, China.
  • Jiang S; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Cao J; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Meng Y; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Xu Y; Department of Bone and Soft Tissue Sarcomas, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • ChunmengWang; Department of Bone and Soft Tissue Sarcomas, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Chen Y; Department of Bone and Soft Tissue Sarcomas, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Yang H; Department of Gynecological Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Kong Y; Department of Pathology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  • Liu X; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China. jeanettexin@hotmail.com.
  • Luo Z; Department of Medical Oncology, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, 200032, China. luozhiguo88@163.com.
Invest New Drugs ; 40(2): 453-460, 2022 04.
Article em En | MEDLINE | ID: mdl-34731354

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endostatinas / Melanoma Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endostatinas / Melanoma Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article